Jeremy C Burns

Title: Innovations by Jeremy C Burns

Introduction

Jeremy C Burns is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of immunology through his innovative research and patent work. His expertise lies in developing methods and agents that modulate protocadherin-18 activity, which has implications for cancer treatment.

Latest Patents

Jeremy C Burns holds a patent titled "Methods and agents for modulating protocadherin-18 activity." This patent describes screening assays and methods for identifying modulator agents or compounds that affect protocadherin-18 mediated inhibition of T cell effector function. The patent encompasses pharmaceutical and immunogenic compositions that include agents or compounds capable of modulating this inhibition. Notably, adenocarcinoma is highlighted as a tumor type that expresses protocadherin-18, and the compositions developed could provide significant benefits to patients suffering from this condition.

Career Highlights

Jeremy C Burns is affiliated with New York University, where he continues to advance his research in immunology and cancer treatment. His work has garnered attention for its potential to improve T cell responses to tumors expressing protocadherin-18.

Collaborations

He has collaborated with notable colleagues, including Edwin J Vazquez-Cintron and Alan B Frey, to further his research initiatives and enhance the impact of his work in the scientific community.

Conclusion

Jeremy C Burns is a prominent inventor whose work in modulating protocadherin-18 activity holds promise for advancing cancer therapies. His contributions to immunology and collaboration with esteemed colleagues underscore his commitment to innovation in the field.